BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 309768)

  • 1. Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a).
    Jacobs JW; Rubin JS; Hugli TE; Bogardt RA; Mariz IK; Daniels JS; Daughaday WH; Bradshaw RA
    Biochemistry; 1978 Nov; 17(23):5031-8. PubMed ID: 309768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid sequence of guinea pig C3a anaphylatoxin.
    Gerard NP; Lively MO; Gerard C
    Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    Hugli TE
    J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the C4a anaphylatoxin from rat.
    Cui L; Ferreri K; Hugli TE
    Mol Immunol; 1988 Jul; 25(7):663-71. PubMed ID: 3262196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human C4a anaphylatoxin.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    J Biol Chem; 1981 Mar; 256(6):2707-11. PubMed ID: 6970745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and crystallization of human anaphylatoxin, C3a.
    Pâques EP; Scholze H; Huber R
    Hoppe Seylers Z Physiol Chem; 1980; 361(6):977-80. PubMed ID: 7399418
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete primary structure of human C4a anaphylatoxin.
    Moon KE; Gorski JP; Hugli TE
    J Biol Chem; 1981 Aug; 256(16):8685-92. PubMed ID: 6167582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN; Hugli TE
    J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.
    Gerard C; Hugli TE
    J Biol Chem; 1979 Jul; 254(14):6346-51. PubMed ID: 447720
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase of glucose and lactate output and decrease of flow by human anaphylatoxin C3a but not C5a in perfused rat liver.
    Püschel GP; Oppermann M; Muschol W; Götze O; Jungermann K
    FEBS Lett; 1989 Jan; 243(1):83-7. PubMed ID: 2784112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.